Skip to main content

Table 5 Birth defects reported from the time of delivery to 14 weeks by exposure group

From: Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

 

Artemether-lumefantrine

(N = 466)

Sulphadoxine-pyrimethamine

(N = 467)

Total number infants with malformations a - n (%)

29/449b (6.5)

18/444b (4.1)

Diagnosis of congenital anomaly/birth defect

  

   Umbilical hernia

21 (4.7)

12 (2.7)

   Polydactyly

3 (0.7)

4 (0.9)

   Dermal cyst

0 (-)

1 (0.2)

   Ear malformation

0 (-)

1 (0.2)

   Genitourinary system: small labiac

1 (0.2)

0 (-)

   Hair: lanugoc

1 (0.2)

0 (-)

   Inguinal hernia

0 (-)

1 (0.2)

   Limbs: hyperextensibility of joint

1 (0.2)

0 (-)

   Nose: smallc

1 (0.2)

0 (-)

   Skin hyperpigmentation

1 (0.2)

0 (-)

   Trisomy 18d

1 (0.2)

0 (-)

   Trisomy 21e

1 (0.2)

0 (-)

  1. Enrolled population: newborn infants.
  2. No distinction was made between major and minor birth defects on the case report form.
  3. aAny malformation = any finding other than normal or any diagnosis of congenital anomaly/birth defect reported.
  4. bNumber of newborn infants with assessment performed at least once at delivery, 6 weeks, or 14 weeks post-delivery. No assessments were available for 17 infants in the AL group and 23 in the SP group.
  5. cReported in the same patient.
  6. dReported malformations: Ears - low set; Mouth - high arched palate; Cranium - microencephaly/anencephaly; Limbs - clenched with overlapping fingers.
  7. eReported malformations: Ears - low set; Mouth - high arched palate; CVS murmur; Chest - short sternum; Cranium - low occiput; Eyes - upward slanting; Mouth - protruding tongue; Neck - short; Nose - low nasal bridge.
  8. In the SP group, one child was reported to have had umbilical hernia and polydactyly.